Navigation Links
Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
Date:9/17/2009

measures provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors are provided with a more meaningful understanding of our ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators we use as a basis for evaluating operational performance, allocating resources and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. To the extent this release contains historical non-GAAP financial measures, we have also provided corresponding GAAP financial measures for comparative purposes.

About Pharmacyclics

Pharmacyclics(R) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is Pharmacyclics' business strategy to establish collaborations with large pharmaceutical and biotechnology companies for the purpose of generating present and future income in exchange for adding to their product pipelines. Pharmacyclics strives to generate collaborations that allow it to retain valuable territorial rights and simultaneou
'/>"/>

SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Pharmacyclics Sets Record Date for Rights Offering
2. Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
3. Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
4. Pharmacyclics Receives Nasdaq Notification
5. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
6. Pharmacyclics Reports Third Quarter 2008 Financial Results
7. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
8. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
9. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
10. J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance
11. Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Ticket Down is a reputable source for ... Santa Clara, California. Fans in the United States of international soccer ... club and national teams in the world. Coming off the heels ... the best time to be a fan of soccer in the ... on American soil this year, as well as international friendly games ...
(Date:7/31/2014)... 2014 David Kekich, anti-aging icon ... ) is thrilled that the acceptance of his ... Artificial Intelligence (AI) algorithms and then screening thousands ... acceptance. , “It took longer than ... proof is in," said Kekich. "Client acceptance is ...
(Date:7/31/2014)... 2014 Much of the liver,s metabolic function is ... and UC Irvine researchers have now found two ... published online today in Cell , reveals new ... points the way to more focused drug treatments for ... diabetes. , Paolo Sassone-Corsi, UCI,s Donald Bren Professor of ...
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 ... business-to-business publication dedicated to delivering cutting-edge information ... biopharmaceuticals and therapeutics, recently launched its newly ... new website optimizes navigation by providing visitors ... manufacturing, analytical and strategic business areas. As ...
(Date:7/31/2014)... teens never outgrow their "growing pains," according to new ... affecting teens, participation in sports and other activities, a ... can become chronic, the researchers cautioned. "We can ... people between the ages of 12 and 19 experience ... Rathleff, a physiotherapist from Aarhus University. "Seven percent of ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 2Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 3Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2Health News:BioProcess International Launches New Website 2Health News:Teen 'Growing Pains' May Persist For Years 2
... , CLEVELAND, Aug. 12 The Sisters of Charity ... its legal department. Jerse will serve as General Counsel to St. ... Counsel for the health system. , , "We ... expertise that Shannon brings to this new position," says Sister Judith ...
... patients, survey found , WEDNESDAY, Aug. 12 (HealthDay News) ... problems, according to the results of a patient survey. ... 78, who had two types of cervical neck operations ... Before the surgery, 86.4 percent of the patients reported ...
... NEW YORK, Aug. 12 Gloria Gibbons, President of Ogilvy ... have been appointed Joint Worldwide CEOs of Ogilvy Healthworld, reporting to ... In making the announcement, Mr. Young said, "Donna and Gloria ... individuals. Their joint mandate is to drive the business as ...
... ... business culture and long history of technology innovation to enhance research, development and innovation ... Scottsdale, AZ ... management and security, today announced the expansion of its global operations with the opening ...
... now the greatest threat to the health of Americans, finding an effective ... a new study in the August 2009 issue of the ... portion and calorie-controlled meal replacements used in a structured weight-loss program are ... The st u dy looked at ...
... , SWARTZ CREEK, Mich., Aug. 12 Diplomat ... 2009 Inc. 500, Inc.,s annual ranking of the fastest-growing ... at 235 in the nation is an amazing achievement, the additional details are ... Hagerman refers to are these: , , , ...
Cached Medicine News:Health News:Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 2Health News:Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 3Health News:Surgery for Neck Pain May Also Relieve Headaches 2Health News:Joint Worldwide CEO's of Ogilvy Healthworld Named 2Health News:Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 2Health News:Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 3Health News:New Published Diet Study Reveals Meal Replacements as Top Strategy for Weight Loss 2Health News:Diplomat Specialty Pharmacy Honored By Inc. Magazine As One Of The Nation's Fastest-Growing Companies 2
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 /PRNewswire/ ... committee members—who make decisions about which therapies are ... influence formulary placement, according to a new Manhattan ... Makers 2014 . The study finds that P&T ... and pharmacy benefits managers (PBMs) have set a ...
(Date:7/31/2014)... Calif. , July 31, 2014 Touro ... it has been selected as the recipient of a ... which will allow the University to increase research and ... about creating state-of-the-art technology for the study of health ... enhance the diverse needs and interests of our students," ...
(Date:7/31/2014)... Lazarus Effect, a medical device company focused ... removal of blood clots, announced the closing of a ... EU commercialization of several approved Lazarus Effect devices, as ... Lazarus Cover™ in the United States ... the value of our novel, platform technology as well ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Touro University California Garners Grant From Long Foundation 2Lazarus Effect Closes $5 Million Financing 2
... May 10, 2011 The following is being released ... 20 years, the federal government has publicly denied a ... Injury Compensation Program (VICP) has been awarding damages for ... autism. A new investigation, based on verifiable government data, ...
... 10, 2011 Who:More than 3,800 Life Technologies employees in ... company paid time today to support the communities in which ... to interview employees about what giving back to the community ... pitch in if you,d like! When:Wednesday, May 11, 2011, 9 AM ...
Cached Medicine Technology:83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: